FDA NDC Directory · JSON-LD · Markdown

Morphine Sulfate

NDC 0832-0227 · HUMAN PRESCRIPTION DRUG · CAPSULE, EXTENDED RELEASE

Labeler / ManufacturerUpsher-Smith Laboratories, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA202104
Dosage form / routeCAPSULE, EXTENDED RELEASE · ORAL
Active ingredientsMORPHINE SULFATE (30 mg/1)
Marketing started20130630
Package count2

External sources

Source: openFDA. Public-domain (CC0).